Biotechnology in Europe industry profile provides top-line qualitative and quantitative summary information including: market size (value 2006-10, and forecast to 2015). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Europe biotechnology market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Highlights

The biotechnology market consists of the development, manufacturing and marketing of products based on advanced biotechnology research. The market value reflects revenues of companies within this industry from product sales, licensing fees, royalties and research funding. Any currency conversions used in the creation of this report have been calculated using constant 2011 annual average exchange rates.
The European biotechnology market had total revenue of $65,544.7 million in 2010, representing a compound annual growth rate (CAGR) of 10.7% between 2006 and 2010.
Medical/Healthcare sales proved the most lucrative for the European biotechnology market in 2010, with total revenues of $51,263.1 million, equivalent to 78.2% of the market's overall value.
The performance of the market is forecast to decelerate, with an anticipated CAGR of 7.4% for the five-year period 2010 - 2015, which is expected to drive the market to a value of $93,831.6 million by the end of 2015.

Features

Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Europe

Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Europe

Leading company profiles reveal details of key biotechnology market players' global operations and financial performance

Add weight to presentations and pitches by understanding the future growth prospects of the Europe biotechnology market with five year forecasts

Macroeconomic indicators provide insight into general trends within the Europe economy

Key Questions Answered

What was the size of the Europe biotechnology market by value in 2010?

What will be the size of the Europe biotechnology market in 2015?

What factors are affecting the strength of competition in the Europe biotechnology market?

How has the market performed over the last five years?

What are the main segments that make up Europe's biotechnology market?

EXECUTIVE SUMMARY
MARKET OVERVIEW
- Market definition
- Research highlights
- Market analysis
MARKET VALUE
MARKET SEGMENTATION I
MARKET SEGMENTATION II
FIVE FORCES ANALYSIS
- Summary
- Buyer power
- Supplier power
- New entrants
- Substitutes
- Rivalry
LEADING COMPANIES
- Astra Zeneca
- Boehringer Ingelheim
- Merck KGaA
- Novartis AG
MARKET FORECASTS
- Market value forecast
APPENDIX
- Methodology
- Industry associations
- Related Datamonitor research
- Disclaimer
ABOUT DATAMONITOR
- Premium Reports
- Summary Reports
- Datamonitor consulting
LIST OF TABLES
- Table 1: Europe biotechnology market value: $ million, 2006-10
- Table 2: Europe biotechnology market segmentation I:% share, by value, 2010
- Table 3: Europe biotechnology market segmentation II: % share, by value, 2010
- Table 4: Astra Zeneca: key facts
- Table 5: Astra Zeneca: key financials ($)
- Table 6: Astra Zeneca: key financial ratios
- Table 7: Boehringer Ingelheim : key facts
- Table 8: Boehringer Ingelheim : key financials ($)
- Table 9: Boehringer Ingelheim : key financials (€)
- Table 10: Boehringer Ingelheim : key financial ratios
- Table 11: Merck KGaA: key facts
- Table 12: Merck KGaA: key financials ($)
- Table 13: Merck KGaA: key financials (€)
- Table 14: Merck KGaA: key financial ratios
- Table 15: Novartis AG: key facts
- Table 16: Novartis AG: key financials ($)
- Table 17: Novartis AG: key financial ratios
- Table 18: Europe biotechnology market value forecast: $ million, 2010-15
LIST OF FIGURES
- Figure 1: Europe biotechnology market value: $ million, 2006-10
- Figure 2: Europe biotechnology market segmentation I:% share, by value, 2010
- Figure 3: Europe biotechnology market segmentation II: % share, by value, 2010
- Figure 4: Forces driving competition in the biotechnology market in Europe, 2010
- Figure 5: Drivers of buyer power in the biotechnology market in Europe, 2010
- Figure 6: Drivers of supplier power in the biotechnology market in Europe, 2010
- Figure 7: Factors influencing the likelihood of new entrants in the biotechnology market in Europe, 2010
- Figure 8: Factors influencing the threat of substitutes in the biotechnology market in Europe, 2010
- Figure 9: Drivers of degree of rivalry in the biotechnology market in Europe, 2010
- Figure 10: Astra Zeneca: revenues & profitability
- Figure 11: Astra Zeneca: assets & liabilities
- Figure 12: Boehringer Ingelheim : revenues & profitability
- Figure 13: Boehringer Ingelheim : assets & liabilities
- Figure 14: Merck KGaA: revenues & profitability
- Figure 15: Merck KGaA: assets & liabilities
- Figure 16: Novartis AG: revenues & profitability
- Figure 17: Novartis AG: assets & liabilities
- Figure 18: Europe biotechnology market value forecast: $ million, 2010-15

Pharmaceutical Market Research

Biotechnology in Europe